News

The biotechnology company Novavax has announced that its COVID-19 vaccine NVX-CoV2373 has a final efficacy of 96.4% against mild, moderate and severe disease.

A research group has developed an algorithm to minimize or maximize the affinity of a given solute to the surface. The findings of the research show that computational methods can contribute in significant ways to next-generation membrane systems for sustainable water treatment.

A new study suggests that cancer cells can dodge chemotherapy by entering a state that bears similarity to certain kinds of senescence, shielding them from aggressive treatments designed to destroy them.

Researchers have discovered a signaling molecule, produced by Schwann cells, that can halt the uncontrolled growth of tumors in malignant and benign neuroblastomas.

Scientists have developed a new highly-selective tool to study “undruggable” proteins, that works by analyzing the sugars they depend on.

Triptonide, a natural compound purified from the vine plant Tripterygium wilfordii Hook F, has been shown to possess reversible contraceptive effects in male mouse and primate models. The findings were published in Nature Communications.

A new study has found that participants who took placebos often reported the same beneficial effects as those that actually microdosed psychedelic substances. Likewise, those who believed they had taken a placebo, when they had taken a psychedelic drug, experienced fewer improvements to their wellbeing.

An early clinical trial in patients with glioblastoma showed an experimental spherical nucleic acid (SNA) drug, developed by Northwestern University scientists, was able to penetrate the blood–brain barrier and trigger the destruction of tumor cells.

New research shows a strong connection in rodent models between brain activity and behaviors resulting from psychedelic treatment, a step forward in the quest to better understand their potential therapeutic effects.

A new study shows that whole genome sequencing is often more accurate than conventional genetic tests and could help determine the treatment for blood cancers such as acute myeloid leukemia and myelodysplastic syndrome.